Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Targeting inflammation by modulating the Jun/AP-1 pathway.

Schonthaler HB, Guinea-Viniegra J, Wagner EF.

Ann Rheum Dis. 2011 Mar;70 Suppl 1:i109-12. doi: 10.1136/ard.2010.140533. Review.

PMID:
21339212
2.

Signalling in inflammatory skin disease by AP-1 (Fos/Jun).

Uluçkan Ö, Guinea-Viniegra J, Jimenez M, Wagner EF.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 92):S44-9. Epub 2015 Oct 12. Review.

PMID:
26458100
3.

Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun).

Wagner EF.

Ann Rheum Dis. 2010 Jan;69 Suppl 1:i86-88. doi: 10.1136/ard.2009.119396. Review.

PMID:
19995753
4.

TNFalpha shedding and epidermal inflammation are controlled by Jun proteins.

Guinea-Viniegra J, Zenz R, Scheuch H, Hnisz D, Holcmann M, Bakiri L, Schonthaler HB, Sibilia M, Wagner EF.

Genes Dev. 2009 Nov 15;23(22):2663-74. doi: 10.1101/gad.543109.

5.

Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease.

Zenz R, Eferl R, Scheinecker C, Redlich K, Smolen J, Schonthaler HB, Kenner L, Tschachler E, Wagner EF.

Arthritis Res Ther. 2008;10(1):201. doi: 10.1186/ar2338. Epub 2008 Jan 18. Review.

6.

Jun signalling in the epidermis: From developmental defects to psoriasis and skin tumors.

Zenz R, Wagner EF.

Int J Biochem Cell Biol. 2006;38(7):1043-9. Epub 2005 Dec 20. Review.

PMID:
16423552
7.

LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells.

Liu H, Zheng H, Duan Z, Hu D, Li M, Liu S, Li Z, Deng X, Wang Z, Tang M, Shi Y, Yi W, Cao Y.

Mol Cancer. 2009 Oct 27;8:92. doi: 10.1186/1476-4598-8-92.

8.

CD40 induces interleukin-6 gene transcription in dendritic cells: regulation by TRAF2, AP-1, NF-kappa B, AND CBF1.

Mann J, Oakley F, Johnson PW, Mann DA.

J Biol Chem. 2002 May 10;277(19):17125-38. Epub 2002 Mar 8.

9.
10.

Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins.

Zenz R, Eferl R, Kenner L, Florin L, Hummerich L, Mehic D, Scheuch H, Angel P, Tschachler E, Wagner EF.

Nature. 2005 Sep 15;437(7057):369-75. Erratum in: Nature. 2006 Mar 30;440(7084):708.

PMID:
16163348
11.

Transcriptional control of K5, K6, K14, and K17 keratin genes by AP-1 and NF-kappaB family members.

Ma S, Rao L, Freedberg IM, Blumenberg M.

Gene Expr. 1997;6(6):361-70.

PMID:
9495317
12.
16.

Differential induction of nuclear factor-kappaB and activator protein-1 activity after CD40 ligation is associated with primary human hepatocyte apoptosis or intrahepatic endothelial cell proliferation.

Ahmed-Choudhury J, Russell CL, Randhawa S, Young LS, Adams DH, Afford SC.

Mol Biol Cell. 2003 Apr;14(4):1334-45. Erratum in: Mol Biol Cell.2003 May;14(5):following table of contents. Choudhury JA [corrected to Ahmed-Choudhury J].

17.

Mechanism of the tumor necrosis factor alpha-mediated induction of endothelial tissue factor.

Bierhaus A, Zhang Y, Deng Y, Mackman N, Quehenberger P, Haase M, Luther T, Müller M, Böhrer H, Greten J, et al.

J Biol Chem. 1995 Nov 3;270(44):26419-32.

18.

Inflammatory cytokine expression is independent of the c-Jun N-terminal kinase/AP-1 signaling cascade in human neutrophils.

Cloutier A, Ear T, Borissevitch O, Larivée P, McDonald PP.

J Immunol. 2003 Oct 1;171(7):3751-61.

19.

The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity.

Basbous J, Arpin C, Gaudray G, Piechaczyk M, Devaux C, Mesnard JM.

J Biol Chem. 2003 Oct 31;278(44):43620-7. Epub 2003 Aug 22.

20.

From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance.

Karin M, Gallagher E.

IUBMB Life. 2005 Apr-May;57(4-5):283-95. Review.

Items per page

Supplemental Content

Write to the Help Desk